CoChat
Sign Up
Cited by 132Toxic Organic Pollutants ImpactGenomics, phytochemicals, and oxidative stressPharmacogenetics and Drug Metabolism

The DOI matches its Crossref record; 371 of the 379 references it cites were found in a registry or an index.

Aryl Hydrocarbon Receptor in Oxidative Stress as a Double Agent and Its Biological and Therapeutic Significance

Open access
Grishanova, Alevtina Y., Perepechaeva, Maria L.·2022·International Journal of Molecular Sciences
DOI 10.3390/ijms23126719PMC PMC9224361
Open this paper in CoChat — free accountOpen PDF

Abstract

The aryl hydrocarbon receptor (AhR) has long been implicated in the induction of a battery of genes involved in the metabolism of xenobiotics and endogenous compounds. AhR is a ligand-activated transcription factor necessary for the launch of transcriptional responses important in health and disease. In past decades, evidence has accumulated that AhR is associated with the cellular response to oxidative stress, and this property of AhR must be taken into account during investigations into a mechanism of action of xenobiotics that is able to activate AhR or that is susceptible to metabolic activation by enzymes encoded by the genes that are under the control of AhR. In this review, we examine various mechanisms by which AhR takes part in the oxidative-stress response, including antioxidant and prooxidant enzymes and cytochrome P450. We also show that AhR, as a participant in the redox balance and as a modulator of redox signals, is being increasingly studied as a target for a new class of therapeutic compounds and as an explanation for the pathogenesis of some disorders.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/ijms23126719

Cites

371 of 371 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Structure of aryl hydrocarbon receptor (AhR). The basic helix–loop–helix (bHLH) motif, common among various transcription factors, is located at the N terminus of the AhR protein and is involved in DNA binding and protein–protein interactions. Per–ARNT–Sim (PAS) domains (PAS-A and PAS-B) participate in binding to ligands and to HSP90 proteins and in dimerization with partner proteins. The transactivation domain (TAD) is located at the C terminus of the AhR protein.
Figure 1 Structure of aryl hydrocarbon receptor (AhR). The basic helix–loop–helix (bHLH) motif, common among various transcription factors, is located at the N terminus of the AhR protein and is involved in DNA binding and protein–protein interactions. Per–ARNT–Sim (PAS) domains (PAS-A and PAS-B) participate in binding to ligands and to HSP90 proteins and in dimerization with partner proteins. The transactivation domain (TAD) is located at the C terminus of the AhR protein.CC BY · PubMed Central
Figure 2 An outline of canonical and non-canonical AhR signaling pathways. Under physiological conditions, AhR is localized to the cytosol and forms a complex with specific proteins, such as hepatitis B virus X-associated protein 2 (XAP-2), heat shock protein 90 (HSP90), cytosolic endoplasmic-reticulum proteins, and protein tyrosine kinase c-Src. After binding to a ligand, AhR changes its conformation and relocates to the nucleus, where it dimerizes with AhR nuclear transporter (ARNT) or other partners such as transcription factor Krüppel-like factor 6 (KLF6) or transcription factors of the nuclear factor kappa B (NF-κB) family (e.g., RelB). Dissociated c-Src interacts with epidermal growth factor receptor (EGFR). AhR signaling is connected with the activity and function of estrogen receptor and E2 promoter-binding factor 1 (E2F1), which is capable of binding to pRB. The AhR–ARNT complex binds to a xenobiotic-responsive element (XRE) and induces the transcription of AhR-controlled genes. Proteins AhR and KLF6 form a heterodimer that recognizes a novel non-consensus XRE (NC-XRE) and initiates the transcription of genes involved in cell cycle regulation. Proteins AhR and RelB (an NF-κB subunit) combine into a heterodimer that recognizes a RelB–XRE complex and induces the transcription of some chemokine genes. AhR and NF-κB form a heterodimer that lead to the inducing of the expression of cytokines and chemokines B-cell-activating factor of the tumor necrosis factor family (BAFF), B-lymphocyte chemoattractant (BLC), CC-chemokine ligand 1 (CCL1), and interferon-responsive factor (IFR3). The AhR/ARNT/NF-κB interaction decreases the expression of CYP1A1. AhR and pRb form a heterodimer that lead to a blocked cell cycle progression by suppressing the expression of S-phase genes. AhR activity is controlled by negative feedback loops, including the metabolism of ligands, the disruption of the AhR/ARNT complex by AhR repressor (AhRR), and proteosomal degradation by the ubiquitin ligase complex. AhR in complex with ER promotes the proteolysis of ER by ubiquitin ligase complex.
Figure 2 An outline of canonical and non-canonical AhR signaling pathways. Under physiological conditions, AhR is localized to the cytosol and forms a complex with specific proteins, such as hepatitis B virus X-associated protein 2 (XAP-2), heat shock protein 90 (HSP90), cytosolic endoplasmic-reticulum proteins, and protein tyrosine kinase c-Src. After binding to a ligand, AhR changes its conformation and relocates to the nucleus, where it dimerizes with AhR nuclear transporter (ARNT) or other partners such as transcription factor Krüppel-like factor 6 (KLF6) or transcription factors of the nuclear factor kappa B (NF-κB) family (e.g., RelB). Dissociated c-Src interacts with epidermal growth factor receptor (EGFR). AhR signaling is connected with the activity and function of estrogen receptor and E2 promoter-binding factor 1 (E2F1), which is capable of binding to pRB. The AhR–ARNT complex binds to a xenobiotic-responsive element (XRE) and induces the transcription of AhR-controlled genes. Proteins AhR and KLF6 form a heterodimer that recognizes a novel non-consensus XRE (NC-XRE) and initiates the transcription of genes involved in cell cycle regulation. Proteins AhR and RelB (an NF-κB subunit) combine into a heterodimer that recognizes a RelB–XRE complex and induces the transcription of some chemokine genes. AhR and NF-κB form a heterodimer that lead to the inducing of the expression of cytokines and chemokines B-cell-activating factor of the tumor necrosis factor family (BAFF), B-lymphocyte chemoattractant (BLC), CC-chemokine ligand 1 (CCL1), and interferon-responsive factor (IFR3). The AhR/ARNT/NF-κB interaction decreases the expression of CYP1A1. AhR and pRb form a heterodimer that lead to a blocked cell cycle progression by suppressing the expression of S-phase genes. AhR activity is controlled by negative feedback loops, including the metabolism of ligands, the disruption of the AhR/ARNT complex by AhR repressor (AhRR), and proteosomal degradation by the ubiquitin ligase complex. AhR in complex with ER promotes the proteolysis of ER by ubiquitin ligase complex.CC BY · PubMed Central
Figure 3 The scheme of putative connections between gene batteries of AhR and Nrf2. (1) Nrf2 is a target gene of AhR; (2) indirect activation of Nrf2 by CYP1A1-generated reactive oxygen species (ROS); and (3) direct interaction of complexes AhR–XRE and Nrf2–ARE in a regulatory region of the NQO1 gene.
Figure 3 The scheme of putative connections between gene batteries of AhR and Nrf2. (1) Nrf2 is a target gene of AhR; (2) indirect activation of Nrf2 by CYP1A1-generated reactive oxygen species (ROS); and (3) direct interaction of complexes AhR–XRE and Nrf2–ARE in a regulatory region of the NQO1 gene.CC BY · PubMed Central
Figure 4 Pro-oxidant and antioxidant effects of AhR results in wide range of physiological and pathological processes in cells and tissues.
Figure 4 Pro-oxidant and antioxidant effects of AhR results in wide range of physiological and pathological processes in cells and tissues.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 379 references

Research works printed but not linked: 1

  1. Prescott, 2000, Cyclooxygellase-2 and carcinogenesis, BBA-Rev. Cancer, 1470, M69

Cited by

Sorted by citations

See all 132

Related

Metadata

Authors
Grishanova, A. Y., & Perepechaeva, M. L.
Affiliations
Federal Research Center of Fundamental and Translational Medicine (RU)
Corresponding author
Perepechaeva, Maria L.
ORCID
Venue
International Journal of Molecular Sciences
Publisher
MDPI AG
Published
2022-06-16
Volume
23
Issue
12
Pages
6719
ISSN
1422-0067 (ISSN-L)
DOI
10.3390/ijms23126719
PMC
PMC9224361
OpenAlex
W4283017800
Cited by
130
References
379
Citations by year
2026: 38 · 2025: 39 · 2024: 32 · 2023: 19 · 2022: 2
FWCI
2.24
Type
journal article
Language
en
Open access
Licence
Locations
  • International Journal of Molecular Sciences (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
budgetary financing project (FGMU-2022-0004, N1021050601082-2-1.6.4;3.1.6)
Topics
  • Physical Sciences › Environmental Science › Health, Toxicology and Mutagenesis › Toxic Organic Pollutants Impact
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics, phytochemicals, and oxidative stress
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
Keywords
aryl hydrocarbon receptor, oxidative stress, xenobiotic metabolism, cytochrome P450, antioxidant enzymes, redox signaling, transcriptional regulation, therapeutic target, pathogenesis
MeSH terms
Gene Expression Regulation, Humans, Xenobiotics, Reactive Oxygen Species, Receptors, Aryl Hydrocarbon, Oxidative Stress

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review